Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)

Fig. 1

Clinical and histopathology images from Dog 6. Significant bilateral periocular and facial alopecia following treatment with difluprednate OU BID for approximately 16 months (a,b). Unilateral regrowth of hair on right side of face approximately 5 months following discontinuation of difluprednate OS (c,d). Alopecia of the distal pinna AD while receiving difluprednate OD BID (e). Photomicrograph from a biopsy of the left ear while receiving difluprednate OU BID (H&E) (f). There is severe follicular atrophy, moderate follicular keratosis, and moderate orthokeratosis. Scale bar = 400 μm

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us